Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
NCT ID: NCT01415531
Last Updated: 2013-05-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
641 participants
INTERVENTIONAL
2011-08-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy
NCT00785512
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension
NCT01218100
Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients
NCT00734630
Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension
NCT03847350
Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension
NCT00547300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
Nebivolol
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
2
Dose-matched placebo
Placebo
Dose-match placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nebivolol
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
Placebo
Dose-match placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with stage 1 or stage 2 essential hypertension
* Normal physical examination findings and electrocardiogram (ECG) results or abnormal findings judged by the Investigator to be not clinically significant
Exclusion Criteria
* History of Type 1 diabetes mellitus
* A medical contraindication to discontinuing a current antihypertensive therapy
* Clinically significant respiratory disease that prohibit use of a beta blocker
18 Years
54 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forest Laboratories
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tatjana Lukic, MD, M. Sc.
Role: STUDY_DIRECTOR
Forest Laboratories
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Forest Investigative Site 065
Phoenix, Arizona, United States
Forest Investigative Site 067
Phoenix, Arizona, United States
Forest Investigative Site 070
Phoenix, Arizona, United States
Forest Investigative Site 049
Buena Park, California, United States
Forest Investigative Site 034
Burbank, California, United States
Forest Investigative Site 039
Costa Mesa, California, United States
Forest Investigative Site 024
Fountain Valley, California, United States
Forest Investigative Site 020
Fresno, California, United States
Forest Investigative Site 021
Fresno, California, United States
Forest Investigative Site 040
Greenbrae, California, United States
Forest Investigative Site 047
La Mesa, California, United States
Forest Investigative Site 073
Los Angeles, California, United States
Forest Investigative Site 077
Roseville, California, United States
Forest Investigative Site 060
San Bernardino, California, United States
Forest Investigative Site 054
San Francisco, California, United States
Forest Investigative Site 018
Spring Valley, California, United States
Forest Investigative Site 028
Denver, Colorado, United States
Forest Investigative Site 059
Brooksville, Florida, United States
Forest Investigative Site 033
Fort Lauderdale, Florida, United States
Forest Investigative Site 006
Hallandale, Florida, United States
Forest Investigative Site 044
Longwood, Florida, United States
Forest Investigative Site 001
Miami, Florida, United States
Forest Investigative Site 012
Miami, Florida, United States
Forest Investigative Site 032
Miami, Florida, United States
Forest Investigative Site 055
Miami, Florida, United States
Forest Investigative Site 045
Oviedo, Florida, United States
Forest Investigative Site 031
St. Petersburg, Florida, United States
Forest Investigative Site 009
Atlanta, Georgia, United States
Forest Investigative Site 007
Chicago, Illinois, United States
Forest Investigative Site 004
Morton, Illinois, United States
Forest Investigative Site 072
Evansville, Indiana, United States
Forest Investigative Site 069
Newburgh, Indiana, United States
Forest Investigative Site 025
Augusta, Kansas, United States
Forest Investigative Site 029
Louisville, Kentucky, United States
Forest Investigative Site 068
Madisonville, Kentucky, United States
Forest Investigative Site 061
Metairie, Louisiana, United States
Forest Investigative Site 057
New Orleans, Louisiana, United States
Forest Investigative Site 058
New Orleans, Louisiana, United States
Forest Investigative Site 008
Lutherville, Maryland, United States
Forest Investigative Site 062
Fall River, Massachusetts, United States
Forest Investigative Site 075
Paw Paw, Michigan, United States
Forest Investigative Site 019
Brooklyn Center, Minnesota, United States
Forest Investigative Site 017
Chaska, Minnesota, United States
Forest Investigative Site 038
Belzoni, Mississippi, United States
Forest Investigative Site 035
Olive Branch, Mississippi, United States
Forest Investigative Site 023
Las Vegas, Nevada, United States
Forest Investigative Site 048
Las Vegas, Nevada, United States
Forest Investigative Site 052
Las Vegas, Nevada, United States
Forest Investigative Site 014
Elizabeth, New Jersey, United States
Forest Investigative Site 051
Trenton, New Jersey, United States
Forest Investigative Site 003
Asheboro, North Carolina, United States
Forest Investigative Site 010
Charlotte, North Carolina, United States
Forest Investigative Site 011
Raleigh, North Carolina, United States
Forest Investigative Site 016
Raleigh, North Carolina, United States
Forest Investigative Site 005
Wilmington, North Carolina, United States
Forest Investigative Site 036
Winston-Salem, North Carolina, United States
Forest Investigative Site 002
Columbus, Ohio, United States
Forest Investigative Site 050
Norman, Oklahoma, United States
Forest Investigative Site 030
Portland, Oregon, United States
Forest Investigative Site 056
Downingtown, Pennsylvania, United States
Forest Investigative Site 022
Pelzer, South Carolina, United States
Forest Investigative Site 053
Beaumont, Texas, United States
Forest Investigative Site 066
Boerne, Texas, United States
Forest Investigative Site 076
Corpus Christi, Texas, United States
Forest Investigative Site 037
Dallas, Texas, United States
Forest Investigative Site 043
Haltom City, Texas, United States
Forest Investigative Site 015
Houston, Texas, United States
Forest Investigative Site 026
Houston, Texas, United States
Forest Investigative Site 027
Houston, Texas, United States
Forest Investigative Site 074
Houston, Texas, United States
Forest Investigative Site 071
Orem, Utah, United States
Forest Investigative Site 042
Sandy City, Utah, United States
Forest Investigative Site 063
Norfolk, Virginia, United States
Forest Investigative Site 064
Norfolk, Virginia, United States
Forest Investigative Site 046
Port Orchard, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEB-MD-28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.